287 related articles for article (PubMed ID: 38136984)
1. Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers.
Anwar S; Yokota T
Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136984
[TBL] [Abstract][Full Text] [Related]
2. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).
Towler OW; Shore EM
Dev Dyn; 2022 Jan; 251(1):164-177. PubMed ID: 34133058
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in drug development for fibrodysplasia ossificans progressiva.
Meng X; Wang H; Hao J
Mol Cell Biochem; 2022 Oct; 477(10):2327-2334. PubMed ID: 35536530
[TBL] [Abstract][Full Text] [Related]
4. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
de Ruiter RD; Smilde BJ; Pals G; Bravenboer N; Knaus P; Schoenmaker T; Botman E; Sánchez-Duffhues G; Pacifici M; Pignolo RJ; Shore EM; van Egmond M; Van Oosterwyck H; Kaplan FS; Hsiao EC; Yu PB; Bocciardi R; De Cunto CL; Longo Ribeiro Delai P; de Vries TJ; Hilderbrandt S; Jaspers RT; Keen R; Koolwijk P; Morhart R; Netelenbos JC; Rustemeyer T; Scott C; Stockklausner C; Ten Dijke P; Triffit J; Ventura F; Ravazzolo R; Micha D; Eekhoff EMW
Front Endocrinol (Lausanne); 2021; 12():732728. PubMed ID: 34858325
[TBL] [Abstract][Full Text] [Related]
5. Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.
Kaplan FS; Al Mukaddam M; Stanley A; Towler OW; Shore EM
Bone; 2020 Nov; 140():115539. PubMed ID: 32730934
[TBL] [Abstract][Full Text] [Related]
6. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
[TBL] [Abstract][Full Text] [Related]
7. Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1.
Aykul S; Huang L; Wang L; Das NM; Reisman S; Ray Y; Zhang Q; Rothman N; Nannuru KC; Kamat V; Brydges S; Troncone L; Johnsen L; Yu PB; Fazio S; Lees-Shepard J; Schutz K; Murphy AJ; Economides AN; Idone V; Hatsell SJ
J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35511419
[TBL] [Abstract][Full Text] [Related]
8. Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva.
Nikishina IP; Arsenyeva SV; Matkava VG; Arefieva AN; Kaleda MI; Smirnov AV; Blank LM; Kostik MM
Pediatr Rheumatol Online J; 2023 Aug; 21(1):92. PubMed ID: 37644581
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles.
Eekhoff EMW; de Ruiter RD; Smilde BJ; Schoenmaker T; de Vries TJ; Netelenbos C; Hsiao EC; Scott C; Haga N; Grunwald Z; De Cunto CL; di Rocco M; Delai PLR; Diecidue RJ; Madhuri V; Cho TJ; Morhart R; Friedman CS; Zasloff M; Pals G; Shim JH; Gao G; Kaplan F; Pignolo RJ; Micha D
Hum Gene Ther; 2022 Aug; 33(15-16):782-788. PubMed ID: 35502479
[TBL] [Abstract][Full Text] [Related]
10. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.
Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC
Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160
[TBL] [Abstract][Full Text] [Related]
11. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Identical Human Mutation in
Casal ML; Engiles JB; Zakošek Pipan M; Berkowitz A; Porat-Mosenco Y; Mai W; Wurzburg K; Xu MQ; Allen R; ODonnell PA; Henthorn PS; Thompson K; Shore EM
Vet Pathol; 2019 Jul; 56(4):614-618. PubMed ID: 31007133
[TBL] [Abstract][Full Text] [Related]
13. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1
Convente MR; Chakkalakal SA; Yang E; Caron RJ; Zhang D; Kambayashi T; Kaplan FS; Shore EM
J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.
Yamamoto M; Stoessel SJ; Yamamoto S; Goldhamer DJ
J Bone Miner Res; 2022 Nov; 37(11):2077-2093. PubMed ID: 35637634
[TBL] [Abstract][Full Text] [Related]
15. Midline brain hamartomatous lesions in fibrodysplasia ossificans progressiva with ACVR1 mutations.
Kresak JL; Walsh M; Tuzzolo A; Ordulu Z; Gregory J
Neuropathology; 2023 Aug; 43(4):333-339. PubMed ID: 36642816
[TBL] [Abstract][Full Text] [Related]
16. Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.
Ratbi I; Bocciardi R; Regragui A; Ravazzolo R; Sefiani A
Clin Rheumatol; 2010 Jan; 29(1):119-21. PubMed ID: 19795179
[TBL] [Abstract][Full Text] [Related]
17. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.
Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN
Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737
[TBL] [Abstract][Full Text] [Related]
18. Fibrodysplasia ossificans progressiva: lessons learned from a rare disease.
Akyuz G; Gencer-Atalay K; Ata P
Curr Opin Pediatr; 2019 Dec; 31(6):716-722. PubMed ID: 31693578
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations for the healthcare of patients with FOP].
Seefried L; Banholzer D; Fischer R; Grafe I; Hüning I; Morhart R; Oheim R; Semler O; Siggelkow H; Stockklausner C; Hoyer-Kuhn H
Orthopadie (Heidelb); 2023 Nov; 52(11):924-930. PubMed ID: 37603129
[TBL] [Abstract][Full Text] [Related]
20. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva.
Towler OW; Shore EM; Kaplan FS
Bone; 2020 Jan; 130():115116. PubMed ID: 31655222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]